 The purpose of this study is to evaluate the effectiveness of treatment with PMIM in patients with visceral leishmaniasis within the VL-endemic region of Bangladesh at EOT 2122 days after treatment begins, and at 6 months after end of treatment Day 202203, -15 to 30 days. 